Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-20-000183
Filing Date
2020-02-14
Accepted
2020-02-14 17:14:21
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.POINT72 HONG KONG LTDSTEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 1) p33099612a.htm SC 13G/A 63194
2 JOINT FILING AGREEMENT p33099612b.htm EX-99.1 3617
  Complete submission text file 0000899140-20-000183.txt   68489
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 20621884
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A